Related Experiment Video
Updated: Sep 25, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
[Osteoporosis: which management strategies in 2026?]
Saha Sadeghipour1, Mathilde Romain1, Emmanuel Biver2
1Service de médecine de premier recours, Département de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.
Abstract:
Osteoporosis is a treatable chronic disease characterized by decreased bone strength and an increased risk of fractures. Due to its insidious progression, it often remains underdiagnosed until a fragility fracture occurs. This condition is associated with significant morbidity, including chronic pain, impaired quality of life, and loss of autonomy, as well as a substantial economic burden related to hospitalizations and increased mortality. Predominantly affecting women, osteoporosis remains largely undertreated, with approximately 80% of eligible women not receiving appropriate therapy. This article outlines diagnostic and therapeutic management strategies for primary care practice, with the aim of improving early detection and reducing the individual and societal burden of the disease.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Bone Remodeling